Search filters

List of works by Holger H H Erb

AR-V7 Protein Expression in Circulating Tumour Cells Is Not Predictive of Treatment Response in mCRPC

scientific article published on 17 January 2020

Assessment of STAT5 as a potential therapy target in enzalutamide-resistant prostate cancer

scientific article published on 13 August 2020

Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.

scientific article

Fractionated Radiation of Primary Prostate Basal Cells Results in Downplay of Interferon Stem Cell and Cell Cycle Checkpoint Signatures

scientific article published on 18 June 2018

Inhibition of the acetyltransferases p300 and CBP reveals a targetable function for p300 in the survival and invasion pathways of prostate cancer cell lines

scientific article published on 27 June 2011

Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.

scientific article published on 21 June 2016

Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics.

scientific article published on 13 December 2017

Mechanistic rationale for MCL1 inhibition during androgen deprivation therapy

scientific article published on March 2015

PIAS1 is increased in human prostate cancer and enhances proliferation through inhibition of p21.

scientific article

PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target

scientific article published on 22 October 2019

Relevance of the natural HDAC inhibitor sulforaphane as a chemopreventive agent in urologic tumors

scientific article published on 17 July 2018

Resolution of Cellular Heterogeneity in Human Prostate Cancers: Implications for Diagnosis and Treatment

scientific article published on 01 January 2019

SOCS3 Modulates the Response to Enzalutamide and Is Regulated by Androgen Receptor Signaling and CpG Methylation in Prostate Cancer Cells.

scientific article published on 6 April 2016

Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways ⬇️

scientific article published on May 3, 2012

The STAT3 inhibitor galiellalactone reduces IL6-mediated AR activity in benign and malignant prostate models

scientific article published on 25 September 2018

The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells

scientific article published on 11 July 2019

The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling.

scientific article published on 29 May 2017

The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancy

scientific article published on 26 March 2019

Therapy escape mechanisms in the malignant prostate

scientific article

Paulina is supported by:

About Paulina

Help